The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
|Articles|August 5, 2011
Practical Aspects of Sexual Education
Advertisement
Advertisement
Related to this article
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
JoAnn V. Pinkerton, MD, MSCP, on elinzanetant across menopause subpopulations at TMS 2026
3
Brain fog at menopause: Separating normal change from dementia
4
What to expect at The Menopause Society's 2026 Annual Meeting
5